Autres langues China Biotech Services Holdings Limited

Actions

8037

BMG2152F1014

Installations et services en soins de santé

Marché Fermé - Hong Kong S.E. 10:08:21 24/08/2026			Varia. 5j.	Varia. 1 janv.
0,6200 ^HKD	0,00%		-0,80%	-21,52%

12/08	China Biotech Services Holdings Limited publie ses prévisions de résultats consolidés pour le semestre clos au 30 juin 2026	CI
12/08	China Biotech Services Holdings Limited et Stella Pharma Corporation concluent un accord de collaboration cadre pour la commercialisation d'un médicament de BNCT	CI

Autres langues

12/08	China Biotech Services Holdings Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 June 2026
12/08	China Biotech Services Holdings Limited and Stella Pharma Corporation Enter Master Collaboration Agreement for Commercialisation of BNCT Drug
03/08	China Biotech Services Holdings Limited's Japan, Pengbo Medical Technology Co., Ltd. Present of Initial Follow-Up Findings of Boron Neutron Capture Therapy At the 22Nd Congress on Neutron Capture Therapy
18/05	China Biotech Services' unit disposes entire stake in PHC Medical Diagnostic Centre, others
30/04	China Biotech Services says He Xun resigns as executive director
30/04	China Biotech Services Holdings Limited Announces Resignation He Xun as Executive Director, Effective May 1, 2026
29/04	China Biotech Services Holdings Limited Auditor Raises 'Going Concern' Doubt
27/03	China Biotech Services Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2025
06/03	China Biotech Services expects FY net loss of not more than HK$100 million
06/03	China Biotech Services Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2025
20/02	China Biotech Services Holdings Limited announced that it has received HKD 272.3 million in funding from Wealth Strategy Holding Ltd
30/12	China Biotech Services to issue convertible bonds
29/12	China Biotech Services Holdings Limited announced that it expects to receive HKD 272.3 million in funding
29/09/25	China Biotech Services says outstanding convertible bonds amount to $6 million
11/09/25	China Biotech Services' unit enters loan contract with Hainan Rural Commercial Bank
27/08/25	China Biotech Services Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2025
08/08/25	China Biotech Services expects loss to be not more than HK$33 million for HY
08/08/25	China Biotech Services Holdings Limited Provides Group Earnings Guidance for the Six Months Ended 30 June 2025
25/07/25	China Biotech Services appoints Yin Ye as executive director
25/07/25	China Biotech Services Holdings Limited Announces Board and Committee Changes
11/07/25	China Biotech Services enters MoU for boron neutron capture therapy insurance product
11/07/25	AXA China Region Insurance Company Limited and AXA International Reinsurance Company Limited Enters into Non-Legally Binding Memorandum of Understanding in Relation to the Collaboration on BNCT Medical Insurance Product
15/05/25	China Biotech Services Holdings Limited Announces Change of Company Secretary
08/05/25	China Biotech Services Signs Memorandum Of Understanding With Stella Pharma Corporation
08/05/25	China Biotech Services Holdings Limited, Pengbo Medical Technology Co., Ltd. and Stella Pharma Corporation Enter into Memorandum of Understanding